Migraine Product X

Type and delivery of treatment

Product X is a treatment for the prevention of migraine and will be given by a healthcare provider in a healthcare setting. It is administered every 3 months by a healthcare professional via an IV infusion (drip) which lasts for 30 minutes. The insights gathered below will potentially assist the manufacturer and healthcare professionals in appropriate administration and educational support of patients.

Healthcare setting is defined as an array of services (including intravenous therapy) and places where healthcare occurs, including, but are not limited to, hospitals, urgent care centres, nursing homes, long term care centres, outpatient surgery centres, clinicians' offices, community sites, schools, and in the home.

This survey is not intended to promote any medicines to the reader. The purpose of this survey is to understand the accessibility of migraine clinics for patients and what are the advantages and disadvantages of migraine prevention therapies.

This survey is anonymous and no personal information is requested or required.

Migraine History and Demographic information

Question Title

* 1. Age

Question Title

* 2. Gender

Female

Male

Prefer not to state

Question Title

* 3. Distance from your nearest migraine centre/hospital

Less than 50 Km

More than 50 Km

Question Title

* 4. Is your migraine centre in the county you live in?

Yes

Question Title

* 5. If you answered no to question 4, how far do you have to travel to your migraine centre?

Question Title

* 6. If you answered no to question 4, what county do you reside in?

Question Title

* 7. How long have you been living with Migraine?

Question Title

* 8. Do you experience:

Episodic Migraine (0-14 headache days per month - with less than 8 migraine headache days per month)

Chronic Migraine (15 or more headache days per month - with 8 or more migraine headache days per month)